SCHEMBL31327730

SCHEMBL31327730

COc1cc2c(cc1C(=O)OC(C)(C)C)sc1nc(-c3ccc(C4CCN(C(=O)OC(C)(C)C)C4)cc3F)cn12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE4B Q07343 4/20 0.47
▸ GPR119 Q8TDV5 4/20 0.39
▸ USP30 Q70CQ3 1/20 0.39
▸ JAK3 P52333 4/20 0.38
▸ JAK2 O60674 3/20 0.38
▸ PTK2 Q05397 3/20 0.38
▸ MEN1 O00255 2/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ ALK Q9UM73 1/20 0.37
▸ TRPV3 Q8NET8 1/20 0.37
▸ PDE4A P27815 1/20 0.37
▸ PDE4C Q08493 1/20 0.37
▸ PDE4D Q08499 1/20 0.37
▸ TLR7 Q9NYK1 1/20 0.36
▸ LCK P06239 1/20 0.36
▸ BTK Q06187 1/20 0.36
▸ ALOX5AP P20292 1/20 0.36
▸ FEN1 P39748 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30727293 0.96 PDE4B (0.46) PDE4BGPR119USP30JAK3JAK2
SCHEMBL26985423 0.96 PDE4B (0.46) PDE4BGPR119USP30JAK3JAK2
SCHEMBL26985441 0.94 PDE4B (0.47) PDE4BGPR119USP30JAK3JAK2
SCHEMBL30727270 0.94 PDE4B (0.47) PDE4BGPR119USP30JAK3JAK2
SCHEMBL26985159 0.94 PDE4B (0.48) PDE4BGPR119USP30JAK3JAK2
SCHEMBL30727304 0.94 PDE4B (0.48) PDE4BGPR119USP30JAK3JAK2
SCHEMBL31327740 0.92 PDE4B (0.45) PDE4BGPR119USP30JAK3JAK2
SCHEMBL26985173 0.92 PDE4B (0.45) PDE4BGPR119USP30JAK3JAK2
SCHEMBL30727281 0.92 PDE4B (0.45) PDE4BGPR119USP30JAK3JAK2
SCHEMBL30727242 0.89 PDE4B (0.42) PDE4BUSP30JAK3PTK2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119255997-A Modulators of c-MYC mRNA translation and their use in the treatment of cancer 艾尼莫生物科技公司 2025-01-03 — — CN disclosed
Send feedback